CN112322735A - 用于前列腺癌复发的预后的基因表达面板 - Google Patents

用于前列腺癌复发的预后的基因表达面板 Download PDF

Info

Publication number
CN112322735A
CN112322735A CN202011258642.3A CN202011258642A CN112322735A CN 112322735 A CN112322735 A CN 112322735A CN 202011258642 A CN202011258642 A CN 202011258642A CN 112322735 A CN112322735 A CN 112322735A
Authority
CN
China
Prior art keywords
prostate cancer
marker genes
individual
predictive model
progression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011258642.3A
Other languages
English (en)
Chinese (zh)
Inventor
玛丽安娜·卡拉·斯特恩
亚采克·平斯基
范建兵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southern California USC
Enlighted Inc
Original Assignee
University of Southern California USC
Enlighted Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southern California USC, Enlighted Inc filed Critical University of Southern California USC
Publication of CN112322735A publication Critical patent/CN112322735A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CN202011258642.3A 2014-01-16 2015-01-16 用于前列腺癌复发的预后的基因表达面板 Pending CN112322735A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461928361P 2014-01-16 2014-01-16
US61/928,361 2014-01-16
CN201580004797.5A CN105917008B (zh) 2014-01-16 2015-01-16 用于前列腺癌复发的预后的基因表达面板

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201580004797.5A Division CN105917008B (zh) 2014-01-16 2015-01-16 用于前列腺癌复发的预后的基因表达面板

Publications (1)

Publication Number Publication Date
CN112322735A true CN112322735A (zh) 2021-02-05

Family

ID=52435027

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201580004797.5A Active CN105917008B (zh) 2014-01-16 2015-01-16 用于前列腺癌复发的预后的基因表达面板
CN202011258642.3A Pending CN112322735A (zh) 2014-01-16 2015-01-16 用于前列腺癌复发的预后的基因表达面板

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201580004797.5A Active CN105917008B (zh) 2014-01-16 2015-01-16 用于前列腺癌复发的预后的基因表达面板

Country Status (7)

Country Link
US (3) US10364469B2 (enExample)
EP (1) EP3094747B1 (enExample)
JP (1) JP6666852B2 (enExample)
CN (2) CN105917008B (enExample)
AU (3) AU2015206336B2 (enExample)
CA (1) CA2935720A1 (enExample)
WO (1) WO2015109234A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10364469B2 (en) 2014-01-16 2019-07-30 Illumina, Inc Gene expression panel for prognosis of prostate cancer recurrence
WO2019018684A1 (en) * 2017-07-21 2019-01-24 The Board Of Trustees Of The Leland Stanford Junior University SYSTEMS AND METHODS FOR ANALYZING MIXED CELL POPULATIONS
IL319255A (en) 2017-08-07 2025-04-01 Univ Johns Hopkins Methods and materials for cancer assessment and treatment
CN107699564B (zh) * 2017-10-23 2019-09-20 中国科学院苏州生物医学工程技术研究所 人前列腺癌早期诊断用长链非编码rna序列及其应用
US10769783B2 (en) * 2018-02-09 2020-09-08 Case Western Reserve University Predicting prostate cancer biochemical recurrence using combined nuclear NF-KB/P65 localization and gland morphology
DE202019005627U1 (de) 2018-04-02 2021-05-31 Grail, Inc. Methylierungsmarker und gezielte Methylierungssondenpanels
US11348239B2 (en) 2018-05-14 2022-05-31 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides
US10957041B2 (en) 2018-05-14 2021-03-23 Tempus Labs, Inc. Determining biomarkers from histopathology slide images
US11741365B2 (en) 2018-05-14 2023-08-29 Tempus Labs, Inc. Generalizable and interpretable deep learning framework for predicting MSI from histopathology slide images
US11348240B2 (en) * 2018-05-14 2022-05-31 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides
US11348661B2 (en) 2018-05-14 2022-05-31 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides
AU2019351130B2 (en) 2018-09-27 2025-10-23 GRAIL, Inc Methylation markers and targeted methylation probe panel
US12325879B2 (en) 2018-10-31 2025-06-10 Regents Of The University Of Minnesota Methods for predicting a response to bevacizumab or platinum-based chemotherapy or both in patients with ovarian cancer
CA3126990A1 (en) * 2019-02-14 2020-08-20 Maneesh Jain Methods and systems for determining a pregnancy-related state of a subject
WO2020225551A1 (en) * 2019-05-08 2020-11-12 Oxford BioDynamics PLC Chromosome conformation markers of prostate cancer and lymphoma
CN110706749B (zh) * 2019-09-10 2022-06-10 至本医疗科技（上海）有限公司 一种基于组织器官分化层次关系的癌症类型预测系统和方法
GB201915464D0 (en) * 2019-10-24 2019-12-11 Uea Enterprises Ltd Novel biomarkers and diagnostic profiles for prostate cancer
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
KR102139313B1 (ko) * 2020-02-27 2020-07-29 이화여자대학교 산학협력단 알츠하이머병 치매 조기 진단을 위한 후성 유전학적 진단 키트 개발
KR102139315B1 (ko) * 2020-02-27 2020-07-29 이화여자대학교 산학협력단 Tnfrsf19 유전자의 dna 메틸레이션 변화를 이용한 알츠하이머병 치매 조기진단 마커
WO2021253134A1 (en) * 2020-06-18 2021-12-23 Ontario Institute For Cancer Research (Oicr) Molecular classifiers for prostate cancer
EP3960877A1 (en) * 2020-08-31 2022-03-02 Koninklijke Philips N.V. Prediction of a response of a prostate cancer subject to therapy or personalization of therapy of a prostate cancer subject
WO2022147503A1 (en) * 2020-12-31 2022-07-07 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides
WO2023058100A1 (ja) 2021-10-04 2023-04-13 国立大学法人 東京大学 構造多型の検出方法、プライマーセット及びプライマーセットの設計方法
WO2024229244A2 (en) * 2023-05-03 2024-11-07 Mirvie, Inc. Methods and systems for determining a pregnancy-related state of a subject

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006066965A2 (en) * 2004-12-24 2006-06-29 Stichting, Katholieke Universiteit, The Universitymedical Mrna ratios in urinary sediments and/or urine as a prognostic and/or theranostic marker for prostate cancer
US20100086935A1 (en) * 2001-11-09 2010-04-08 Source Precision Medicine, Inc. Identification, Monitoring and Treatment of Disease and Characterization of Biological Condition Using Gene Expression Profiles
WO2012015765A2 (en) * 2010-07-27 2012-02-02 Genomic Health, Inc. Method for using gene expression to determine prognosis of prostate cancer
WO2012170715A1 (en) * 2011-06-07 2012-12-13 Caris Mpi, Inc. Molecular profiling for cancer
US20120329713A1 (en) * 2008-02-21 2012-12-27 Klem Robert E Method for determining likelihood of clinical recurrence or clinically stable disease of prostate cancer after radical prostatectomy
WO2013116144A1 (en) * 2012-01-31 2013-08-08 Genomic Health, Inc. Gene expression profile algorithm and test for determining prognosis of prostate cancer
WO2013184851A1 (en) * 2012-06-05 2013-12-12 Iris International, Inc. Method for determining recurrence or stable disease after treatment for prostate cancer

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469863A (en) 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
GB8822228D0 (en) 1988-09-21 1988-10-26 Southern E M Support-bound oligonucleotides
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
DE3924454A1 (de) 1989-07-24 1991-02-07 Cornelis P Prof Dr Hollenberg Die anwendung von dna und dna-technologie fuer die konstruktion von netzwerken zur verwendung in der chip-konstruktion und chip-produktion (dna chips)
US5252743A (en) 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US5386023A (en) 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
ES2097925T3 (es) 1991-09-18 1997-04-16 Affymax Tech Nv Metodo para sintetizar diversas colecciones de oligomeros.
US5324633A (en) 1991-11-22 1994-06-28 Affymax Technologies N.V. Method and apparatus for measuring binding affinity
WO1993009668A1 (en) 1991-11-22 1993-05-27 Affymax Technology N.V. Combinatorial strategies for polymer synthesis
US5644048A (en) 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
DE69333650T2 (de) 1992-02-19 2006-01-12 The Public Health Research Institute Of The City Of New York, Inc. Neue anordnungn von oligonukleotiden und ihr nutzen zum sortieren, isolieren, sequenzieren und manipulieren von nukleinsäuren
US5583211A (en) 1992-10-29 1996-12-10 Beckman Instruments, Inc. Surface activated organic polymers useful for location - specific attachment of nucleic acids, peptides, proteins and oligosaccharides
US5491074A (en) 1993-04-01 1996-02-13 Affymax Technologies Nv Association peptides
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5472672A (en) 1993-10-22 1995-12-05 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and method for polymer synthesis using arrays
US5429807A (en) 1993-10-28 1995-07-04 Beckman Instruments, Inc. Method and apparatus for creating biopolymer arrays on a solid support surface
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US6090555A (en) 1997-12-11 2000-07-18 Affymetrix, Inc. Scanned image alignment systems and methods
US5637684A (en) 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
WO1995030774A1 (en) 1994-05-05 1995-11-16 Beckman Instruments, Inc. Oligonucleotide repeat arrays
US5571639A (en) 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US5795716A (en) 1994-10-21 1998-08-18 Chee; Mark S. Computer-aided visualization and analysis system for sequence evaluation
US5599695A (en) 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
US5624711A (en) 1995-04-27 1997-04-29 Affymax Technologies, N.V. Derivatization of solid supports and methods for oligomer synthesis
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US5968740A (en) 1995-07-24 1999-10-19 Affymetrix, Inc. Method of Identifying a Base in a Nucleic Acid
DE69638321D1 (de) 1995-10-11 2011-03-03 Luminex Corp Gleichzeitige mehrfachanalyse klinischer proben
US5658734A (en) 1995-10-17 1997-08-19 International Business Machines Corporation Process for synthesizing chemical compounds
US6022963A (en) 1995-12-15 2000-02-08 Affymetrix, Inc. Synthesis of oligonucleotide arrays using photocleavable protecting groups
EP0902885A4 (en) 1996-05-16 2006-09-27 Affymetrix Inc SYSTEMS AND METHODS FOR DETECTION OF BRANDED PRODUCTS
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
ATE234674T1 (de) 1996-11-14 2003-04-15 Affymetrix Inc Chemische amplifizierung zur synthese von musterordnungen
US6297006B1 (en) 1997-01-16 2001-10-02 Hyseq, Inc. Methods for sequencing repetitive sequences and for determining the order of sequence subfragments
US6023540A (en) 1997-03-14 2000-02-08 Trustees Of Tufts College Fiber optic sensor with encoded microspheres
US6327410B1 (en) 1997-03-14 2001-12-04 The Trustees Of Tufts College Target analyte sensors utilizing Microspheres
WO1999023254A1 (en) 1997-10-31 1999-05-14 Affymetrix, Inc. Expression profiles in adult and fetal organs
US6087102A (en) 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US6428752B1 (en) 1998-05-14 2002-08-06 Affymetrix, Inc. Cleaning deposit devices that form microarrays and the like
US6287776B1 (en) 1998-02-02 2001-09-11 Signature Bioscience, Inc. Method for detecting and classifying nucleic acid hybridization
WO1999039817A1 (en) 1998-02-06 1999-08-12 Affymetrix, Inc. Method of quality control in manufacturing processes
JP3944996B2 (ja) 1998-03-05 2007-07-18 株式会社日立製作所 Ｄｎａプローブアレー
US6031078A (en) 1998-06-16 2000-02-29 Millennium Pharmaceuticals, Inc. MTbx protein and nucleic acid molecules and uses therefor
US6277628B1 (en) 1998-10-02 2001-08-21 Incyte Genomics, Inc. Linear microarrays
US6355431B1 (en) 1999-04-20 2002-03-12 Illumina, Inc. Detection of nucleic acid amplification reactions using bead arrays
US20030207295A1 (en) 1999-04-20 2003-11-06 Kevin Gunderson Detection of nucleic acid reactions on bead arrays
ATE413467T1 (de) 1999-04-20 2008-11-15 Illumina Inc Detektion von nukleinsäurereaktionen auf kügelchen-arrays
US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
US6913884B2 (en) 2001-08-16 2005-07-05 Illumina, Inc. Compositions and methods for repetitive use of genomic DNA
US20040121364A1 (en) 2000-02-07 2004-06-24 Mark Chee Multiplex nucleic acid reactions
EP1990428B1 (en) 2000-02-07 2010-12-22 Illumina, Inc. Nucleic acid detection methods using universal priming
US7955794B2 (en) 2000-09-21 2011-06-07 Illumina, Inc. Multiplex nucleic acid reactions
US7611869B2 (en) 2000-02-07 2009-11-03 Illumina, Inc. Multiplexed methylation detection methods
US6770441B2 (en) 2000-02-10 2004-08-03 Illumina, Inc. Array compositions and methods of making same
JP2001244419A (ja) * 2000-02-28 2001-09-07 Hitachi Ltd 高周波モジュール及び移動体検知モジュール
US6489606B1 (en) 2000-04-07 2002-12-03 Cidra Corporation Bragg grating sensor system with spectral response or code division multiplexing
AU8288101A (en) * 2000-07-07 2002-01-21 Visigen Biotechnologies Inc Real-time sequence determination
US20040018491A1 (en) 2000-10-26 2004-01-29 Kevin Gunderson Detection of nucleic acid reactions on bead arrays
US8288641B2 (en) * 2001-12-27 2012-10-16 Intel Corporation Portable hand-held music synthesizer and networking method and apparatus
US20040029151A1 (en) * 2002-04-09 2004-02-12 Affymetrix, Inc. Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer
US7441703B2 (en) 2002-08-20 2008-10-28 Illumina, Inc. Optical reader for diffraction grating-based encoded optical identification elements
JP2005536769A (ja) 2002-08-20 2005-12-02 シヴェラ コーポレイション 回折格子をベースとする光学同定要素
US20050227252A1 (en) 2002-08-20 2005-10-13 Moon John A Diffraction grating-based encoded articles for multiplexed experiments
US7164533B2 (en) 2003-01-22 2007-01-16 Cyvera Corporation Hybrid random bead/chip based microarray
WO2004025562A1 (en) 2002-09-12 2004-03-25 Cyvera Corp. Method and apparatus for labelling using diffraction grating-based encoded optical identification elements
EP1575707A1 (en) 2002-09-12 2005-09-21 Cyvera Corporation Method and apparatus for aligning elongated microbeads in order to interrogate the same
US20040259105A1 (en) 2002-10-03 2004-12-23 Jian-Bing Fan Multiplex nucleic acid analysis using archived or fixed samples
AU2003300368A1 (en) * 2002-12-26 2004-07-29 Cemines, Llc. Methods and compositions for the diagnosis, prognosis, and treatment of cancer
US20050181394A1 (en) 2003-06-20 2005-08-18 Illumina, Inc. Methods and compositions for whole genome amplification and genotyping
EP1673614A1 (en) 2003-10-01 2006-06-28 CiDra Corporation Optical reader for diffraction grating-based encoded optical identification elements
US20060023310A1 (en) 2004-02-19 2006-02-02 Putnam Martin A Optical identification element using separate or partially overlapped diffraction gratings
US7339165B2 (en) 2004-07-09 2008-03-04 Hamilton Sundstrand Corporation Dual outlet pyrolyzer for biological agent detection system
AU2005307746B2 (en) 2004-11-16 2011-05-12 Illumina, Inc. And methods and apparatus for reading coded microbeads
US7914988B1 (en) 2006-03-31 2011-03-29 Illumina, Inc. Gene expression profiles to predict relapse of prostate cancer
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
EA201000427A1 (ru) 2007-10-04 2010-10-29 Хэлсион Молекулар Секвенирование нуклеиново-кислотных полимеров с использованием электронной микроскопии
CA2745961A1 (en) * 2008-12-04 2010-06-10 The Regents Of The University Of California Materials and methods for determining diagnosis and prognosis of prostate cancer
NZ596468A (en) * 2009-05-14 2013-11-29 Nestec Sa Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy
TWM395976U (en) * 2010-06-30 2011-01-01 Tsung-Hung Wu Electret electroacoustic transducer
EP2678448A4 (en) * 2011-02-22 2014-10-01 Caris Life Sciences Luxembourg Holdings S A R L CIRCULATING BIOMARKERS
WO2014022594A1 (en) 2012-07-31 2014-02-06 Daniel Mercola Stroma biomarkers for prostate cancer prognosis
US10364469B2 (en) 2014-01-16 2019-07-30 Illumina, Inc Gene expression panel for prognosis of prostate cancer recurrence

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100086935A1 (en) * 2001-11-09 2010-04-08 Source Precision Medicine, Inc. Identification, Monitoring and Treatment of Disease and Characterization of Biological Condition Using Gene Expression Profiles
WO2006066965A2 (en) * 2004-12-24 2006-06-29 Stichting, Katholieke Universiteit, The Universitymedical Mrna ratios in urinary sediments and/or urine as a prognostic and/or theranostic marker for prostate cancer
US20120329713A1 (en) * 2008-02-21 2012-12-27 Klem Robert E Method for determining likelihood of clinical recurrence or clinically stable disease of prostate cancer after radical prostatectomy
WO2012015765A2 (en) * 2010-07-27 2012-02-02 Genomic Health, Inc. Method for using gene expression to determine prognosis of prostate cancer
WO2012170715A1 (en) * 2011-06-07 2012-12-13 Caris Mpi, Inc. Molecular profiling for cancer
WO2013116144A1 (en) * 2012-01-31 2013-08-08 Genomic Health, Inc. Gene expression profile algorithm and test for determining prognosis of prostate cancer
WO2013184851A1 (en) * 2012-06-05 2013-12-12 Iris International, Inc. Method for determining recurrence or stable disease after treatment for prostate cancer

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AHVA SHAHABI ET AL.: "Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients", 《PROSTATE》, vol. 76, no. 14, pages 1239 - 1256 *
ATISH D.CHOUDHURY ET AL.: "The role of Genetic Markers in the Management of Prostate Cancer", 《EUROPEAN UROLOGY》, vol. 62, no. 4, pages 5877 - 587 *
NONGNUCH NONSRIJUN ET AL.: "Overexpression of Matrix Metalloproteinase 11 in Thai Prostatic Adenocarcinoma is Associated with Poor Survivival", 《ASIAN PACIFIC JOURNAL OF CANCER PREVENTION》, vol. 14, no. 5, pages 3331 - 3335, XP055183507, DOI: 10.7314/APJCP.2013.14.5.3331 *

Also Published As

Publication number Publication date
AU2015206336B2 (en) 2020-01-23
HK1231515A1 (en) 2017-12-22
US20160333420A1 (en) 2016-11-17
EP3094747A1 (en) 2016-11-23
AU2020202145A1 (en) 2020-04-16
US11098372B2 (en) 2021-08-24
CN105917008A (zh) 2016-08-31
WO2015109234A1 (en) 2015-07-23
AU2022203428A1 (en) 2022-06-09
CA2935720A1 (en) 2015-07-23
US20200071770A1 (en) 2020-03-05
CN105917008B (zh) 2020-11-27
US10364469B2 (en) 2019-07-30
US20220033915A1 (en) 2022-02-03
JP6666852B2 (ja) 2020-03-18
AU2015206336A1 (en) 2016-07-14
JP2017503527A (ja) 2017-02-02
EP3094747B1 (en) 2018-11-07

Similar Documents

Publication Publication Date Title
US11098372B2 (en) Gene expression panel for prognosis of prostate cancer recurrence
JP7042717B2 (ja) 癌の臨床転帰を予測する方法
JP6161607B2 (ja) サンプルにおける異なる異数性の有無を決定する方法
CN103403543B (zh) 结肠癌基因表达签名及使用方法
CN110800063A (zh) 使用无细胞dna片段大小检测肿瘤相关变体
JP2007509613A (ja) 遺伝子発現プロファイリングのためのｑＲＴ−ＰＣＲアッセイシステム
Clark-Langone et al. Biomarker discovery for colon cancer using a 761 gene RT-PCR assay
WO2012167112A2 (en) Gastric cancer biomarkers
JP2024028758A (ja) 核酸断片間距離情報を用いた染色体異常検出方法
CN110806480B (zh) 肿瘤特异性细胞亚群和特征基因及其应用
HK40047245A (en) Gene expression panel for prognosis of prostate cancer recurrence
EP4596712A1 (en) Methods of identifying and using biomarkers
HK1231515B (en) Gene expression panel for prognosis of prostate cancer recurrence
Smith et al. Application of DNA-and RNA-based sequencing techniques to tumour tissue samples in the clinical laboratory
WO2025163087A1 (en) Methods of identifying and using biomarkers
Beaver et al. Circulating cell-free DNA for molecular diagnostics and therapeutic monitoring
CN121100192A (zh) 用于鉴定尿液中肾同种异体移植排斥基因的方法和进行这些测量的效用
CN114250297A (zh) 基因突变在结肠癌、肺癌易感基因变异检测中的应用
US20130023427A1 (en) Methods for assessing genomic instabilities in tumors

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40047245

Country of ref document: HK

AD01 Patent right deemed abandoned

Effective date of abandoning: 20250718

AD01 Patent right deemed abandoned